Oncentra Brachy users using version 4.0 and above with… recallZ-0182-2022 · Elekta, Inc. · initiated Oct 13, 2021
Open, Classified
Is my device affected?
- Compare the model, catalog and lot or serial numbers on your device or its packaging with the code information below. A recall usually covers only specific models or lots.
- If yours is listed, follow the instructions from Elekta, Inc. or your healthcare provider. The company's action is summarized under what the company is doing.
- Do not stop using a prescribed or implanted device on your own — talk to your healthcare provider first.
Where to find your model and lot numbers · What recall classes and statuses mean
Why it was recalled
Under certain circumstances, there can be a difference between the planned and delivered dose of the two ovoid channels.
FDA root cause category: Software design
What the company is doing
An Urgent Important Field Safety Notification letter (FAC-NU-0007) was issued to consignees to notify of the issue, clinical impact and recommend the following: 1) Recommended User Action in the unique scenario, which is only applicable for the Venezia" applicator: Avoid use of the combination of the two Venezia" applicator Anchor Points O1-Center and O2-Center by disabling one of them in the Applicator Library Manager. 2)Recommended User Action in the exceptional situation that may also occur for other Applicator Models: Avoid incorrect placement of the Anchor Points, especially exchanging left / right anchor point positions. 3) Recommended User Actions for both scenarios: Until an updated version of Oncentra Brachy is available, it is strongly advised: " To use additional Anchor Points during applicator modelling. This will further reduce the chance of mirroring the Applicator Model. " To cross-check the source dwell position information from the Case Explorer to be in accordance with the source dwell positions in the image views. " Use the Triangles option for the applicator skin visualization in the 3D view, and review whether the Applicator Model has a correct shading display. " Perform proper Quality Assurance for all treatment plans before treatment delivery. Consignees are required to acknowledge receipt of the notification to Elekta within 30 days.
Recall details
- Recall number
- Z-0182-2022
- Status
- Open, Classified
- Initiated by the company
- Oct 13, 2021
- Recalling firm
- Elekta, Inc.
- Quantity
- 1072 devices
- Product code
- MUJ
- FDA submissions
- K132816
- Distribution
- Distribution throughout USA OUS distribution including:Algeria, Argentina, Australia, Austria Bahamas, Bangladesh, Belarus, Belgium, Bolivia, Botswana, Brazil Brunei, Bulgaria, Canada, Chile, China, Colombia, Croatia, Cyprus, Czech Republic, Denmark, Egypt, Estonia, Finland, France, Georgia, Germany, Ghana, Greece, Honduras, Hong Kong, Hungary, Iceland, India, Indonesia, Iran (Islamic Republic of), Ireland, Israel, Italy, Japan, Jordan, Kazakhstan, Kenya, Korea, Republic of, Kosovo, Libyan Arab Jamahiriya, Malaysia, Mexico, Morocco, Netherlands, New Zealand, Norway, Pakistan, Peru, Philippines, Poland, Portugal, Republic of Serbia, Romania, Russian Federation, Saudi Arabia, Senegal, Singapore, Slovakia, South Africa, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, Tunisia, Turkey, Ukraine, United Arab Emirates, United Kingdom, Uzbekistan, Venezuela, Vietnam
Product description
Oncentra Brachy users using version 4.0 and above with Applicator Modeling license 170283-00
Code information (models, lots, serial numbers)
Oncentra Brachy users using version 4.0 and above with Applicator Modeling license 170283-00 GTIN Numbers: 08717213052758, 08717213038660, 08717213020610, 08717213052321, 08717213052314, 08717213052307, 08717213052291, 08717213052246, 08717213052239, 08717213051881, 08717213051843, 08717213051782, 08717213051775, 08717213051294, 08717213020610, 08717213053717, 08717213053700
Devices named in this recall
16 devices in the FDA device registry whose identifier appears in the recall's code information.
- NA 170003-28Nucletron B.V. · System,planning,radiation therapy treatment2 recalls2 reports
- NA 170607-00Nucletron B.V. · System, planning, radiation therapy treatment2 recalls1 report
- NA 170730Nucletron B.V. · System,planning,radiation therapy treatment2 recalls0 reports
- NA Oncentra BrachyNucletron B.V. · System,planning,radiation therapy treatment2 recalls0 reports
- NA 170730Nucletron B.V. · System,planning,radiation therapy treatment2 recalls0 reports
- NA 170003-23Nucletron B.V. · System,planning,radiation therapy treatment2 recalls0 reports
- NA 170537-04Nucletron B.V. · System,planning,radiation therapy treatment2 recalls0 reports
- NA 170003-24Nucletron B.V. · System, applicator, radionuclide, remote-controlled2 recalls0 reports
- NA 170537-05Nucletron B.V. · System,planning,radiation therapy treatment2 recalls0 reports
- NA 170003-25Nucletron B.V. · System,planning,radiation therapy treatment2 recalls0 reports
- NA 170537-06Nucletron B.V. · System,planning,radiation therapy treatment2 recalls0 reports
- NA 170003-27Nucletron B.V. · System,planning,radiation therapy treatment2 recalls0 reports
- NA 170537-06Nucletron B.V. · System,planning,radiation therapy treatment2 recalls0 reports
- NA 170537-08Nucletron B.V. · System,planning,radiation therapy treatment2 recalls0 reports
- NA 170018-00Nucletron B.V. · System, planning, radiation therapy treatment2 recalls0 reports
- NA 170538-00Nucletron B.V. · System, planning, radiation therapy treatment2 recalls0 reports
Sources and updates
- Recall record: FDA Medical Device Recalls, file dated Oct 16, 2026 · View the FDA recall notice ↗
- Devices: FDA GUDID, file dated Oct 13, 2026. Devices are linked when their identifier (with a valid check digit) appears in the recall's code information.
- Page last rebuilt: Oct 16, 2026. Text above is shown as published by the FDA.
How recalls are matched to devices · Editorial policy · Report an error on this page